Skip to main content
SpringerLink
Log in

Ketanserin, an Effective Third-Line Agent in Primary Hypertension

  • Short Communication
  • Poster Presentations: Ketanserin in Essential Hypertension
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Bazett HC. An analysis of the time-relations of electrocardiograms. Heart 7: 353–370, 1920

    Google Scholar 

  • Beilin LJ, Bulpitt CJ, Coles EC, Dollery CT, Gear JSS, et al. Long-term antihypertensive drug therapy and blood pressure control in three hospital hypertension clinics. British Heart Journal 43: 74–79, 1980

    Article  PubMed  CAS  Google Scholar 

  • Beretta-Piccoli C, Arnstein R, Bertel O, Brunner HR, Buhler FR, et al. Antihypertensive efficacy of ketanserin alone or in combination with a β-blocker or a diuretic: the Swiss Ketanserin Study. Journal of Cardiovascular Pharmacology 10(Suppl 3): S119–S123. 1987

    PubMed  Google Scholar 

  • Hansson L, Hedner T. The rationale for ketanserin therapy in hypertension. Journal of Cardiovascular Pharmacology 10(Suppl. 3): S39–S44, 1987

    PubMed  Google Scholar 

  • Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The 1984 report of the joint national committee on the detection, evaluation, and treatment of high blood pressure. Annals of Internal Medicine 144: 1045–1047 1984

    Article  Google Scholar 

  • Maclean D, Vallance BD, Wilcox RG, Muir AL (on behalf of the co-operative study group). Felodipine vs hydralazine: a controlled trial as third line therapy in hypertension. British Journal of Clinical Pharmacology 21: 621–626, 1986

    Article  Google Scholar 

  • McAreavey D, Ramsay LE, Latham L, McLaren AD, Lorimer AR, et al. “Third drug” trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic. British Medical Journal 288: 106–111, 1984

    Article  PubMed  CAS  Google Scholar 

  • Ramsay LE, Parnell L, Waller PC. Comparison of nifedipine, prazosin and hydralazine added to treatment of hypertensive patients uncontrolled by thiazide diuretic plus beta-blocker. Postgraduate Medical Journal 63: 99–103, 1987

    Article  PubMed  CAS  Google Scholar 

  • Stott DJ, Mclenachan JM, Ball SG. Ketanserin, the QT interval, and autonomic function testing. British Journal of Clinical Pharmacology 20: 84P, 1985

    Article  Google Scholar 

  • Van Nueten JM, Janssen PAJ, Van Beek J, Xhonneux R, Vebeuren TJ, et al. Vascular effects of ketanserin, a novel antagonist of 5HT2 serotonergic receptors. Journal of Pharmacology and Therapeutics 218: 217–230, 1981

    Google Scholar 

  • Veterans Administration Co-operative Study Group on Antihypertensive Agents. Propranolol in the treatment of essential hypertension. Journal of the American Medical Association 237: 2303–2310, 1977

    Article  Google Scholar 

  • Waller PC, Solomon SA, Ramsay LE. Comparison of ketanserin and slow release nifedipine added to the treatment of hypertensive patients uncontrolled by a thiazide diuretic plus β-adrenoceptor blocker. British Journal of Clinical Pharmacology 24: 591–597, 1987

    Article  PubMed  CAS  Google Scholar 

  • Woittiez AJJ, Wenting GJ, van den Meiracker AH, Ritsema van Eck HJ, Man in’t Veld AJ, et al. Chronic effect of ketanserin in mild to moderate essential hypertension. Hypertension 8: 167–173, 1986

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University Hospital, Nottingham, NG7 2UH, UK

    J. J. Murphy, P. H. Whincup & R. G. Wilcox

  2. Janssen Pharmaceutical Ltd, Grove, Wantage, UK

    S. E. Gould

Authors
  1. J. J. Murphy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. H. Whincup
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. E. Gould
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. G. Wilcox
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murphy, J.J., Whincup, P.H., Gould, S.E. et al. Ketanserin, an Effective Third-Line Agent in Primary Hypertension. Drugs 36 (Suppl 1), 135–139 (1988). https://doi.org/10.2165/00003495-198800361-00027

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198800361-00027

Keywords

Search

Navigation